Form 8-K - Current report:
SEC Accession No. 0001104659-23-087873
Filing Date
2023-08-04
Accepted
2023-08-04 16:30:21
Documents
14
Period of Report
2023-08-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322858d1_8k.htm   iXBRL 8-K 39308
2 EXHIBIT 10.1 tm2322858d1_ex10-1.htm EX-10.1 15602
  Complete submission text file 0001104659-23-087873.txt   286727

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20230803.xsd EX-101.SCH 3893
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20230803_def.xml EX-101.DEF 27150
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20230803_lab.xml EX-101.LAB 37075
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20230803_pre.xml EX-101.PRE 25774
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2322858d1_8k_htm.xml XML 5715
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 231144452
SIC: 2834 Pharmaceutical Preparations